Foresite Capital Fund VI LP

13D and 13G Filings

13D/G filings
13D on 3 securities, 13G on 5 securities
Location
Larkspur, CA
CIK
0001932516
Form D filings
2 filings
All SEC filings
View on sec.gov
Issuer % of Class Filed
IRulya Therapeutics Inc. 13G
IRLA · 22053A305
6.0% 10/14/2026
Event 10/6/2026
Latigo Biotherapeutics, Inc. 13D
LTGO · 517954103
14.5% 8/17/2026
Event 8/10/2026
Latigo Biotherapeutics, Inc. 13D
LTGO · 517954103
14.5% 8/17/2026
Event 8/10/2026
Verastem, Inc. 13G/A Amendment 1
VSTM · 92337C203
3.6% 5/15/2026
Event 3/31/2026
Alumis Inc. 13D/A Amendment 4
ALMS · 022307102
12.7% 4/3/2026
Event 4/1/2026
CASI Pharmaceuticals, Inc. 13G/A Amendment 3
CASIF · G1933S101
0% 2/13/2026
Event 12/31/2025
Alumis Inc. 13D/A Amendment 3
ALMS · 022307102
14.1% 1/12/2026
Event 1/8/2026
CASI Pharmaceuticals, Inc. 13G/A Amendment 2
CASIF · G1933S101
6.3% 11/14/2025
Event 9/30/2025
Verastem, Inc. 13G
VSTM · 92337C203
5.1% 10/23/2025
Event 10/16/2025
CASI Pharmaceuticals, Inc. 13G/A Amendment 1
CASIF · G1933S101
5.1% 8/12/2025
Event 6/30/2025
Alumis Inc. 13D/A Amendment 2
ALMS · 022307102
15.9% 6/10/2025
Event 5/21/2025
Alumis Inc. 13D/A Amendment 1
ALMS · 022307102
32.2% 5/7/2025
Event 8/13/2024
enGene Holdings, Inc. 13G/A Amendment 1
ENGN · 29286M105
0% 2/14/2025
Event 9/30/2024
RAPT Therapeutics, Inc. 13G
RAPT · 75382E109
9.3% 12/30/2024
Event 12/23/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.